The trading price of Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) closed higher on Monday, April 14, and closing at $0.53, 3.56% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.5219 and $0.5986. In examining the 52-week price action we see that the stock hit a 52-week high of $2.45 and a 52-week low of $0.28. Over the past month, the stock has gained 44.61% in value.
Lexicon Pharmaceuticals Inc, whose market valuation is $191.59 million at the time of this writing, is expected to release its quarterly earnings report on 2025-Mar-05. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest LXRX has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned LXRX a recommendation rating is 3. Out of them, 0 rate it a Hold, while 3 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Lexicon Pharmaceuticals Inc (LXRX) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that LXRX’s price is currently 21.40% off the SMA20 and 0.47% off the SMA50. The RSI metric on the 14-day chart is currently showing 55.62, and weekly volatility stands at 14.96%. When measured over the past 30 days, the indicator reaches 17.07%. Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s beta value is currently sitting at 1.10, while the Average True Range indicator is currently displaying 0.09. With analysts defining $6-$6 as the low and high price targets, we arrive at a consensus price target of $6 for the trailing 12-month period. The current price is about -1032.08% off the estimated low and -1032.08% off the forecast high, based on this estimate. Investors will be thrilled if LXRX’s share price rises to $6, which is the median consensus price. At that level, LXRX’s share price would be -1032.08% below current price.
To see how Lexicon Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: LXRX stock’s performance was 3.56% in the latest trading, and -73.76% in the past year.
An evaluation of the daily trading volume of Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) indicates that the 3-month average is 15.11 million. However, this figure has increased over the past 10 days to an average of 12.62.
Currently, records show that 361.49 million of the company’s shares remain outstanding. The insiders hold 50.33% of outstanding shares, whereas institutions hold 34.83%. The stats also highlight that short interest as of 2025-03-31, stood at 43.88 million shares, resulting in a short ratio of 1.41 at that time. From this, we can conclude that short interest is 2692.00 of the company’s total outstanding shares. It is noteworthy that short shares in March were down slightly from the previous month’s figure, which was 47.46 million. However, since the stock’s price has seen -28.23% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
